Page last updated: 2024-10-18

dalteparin and Superior Vena Cava Obstruction

dalteparin has been researched along with Superior Vena Cava Obstruction in 3 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Concha-Garzon, M1
Sotomayor-Lopez, E1
Solano-Lopez, G1
Fraga, J1
De Argila, D1
Giuliani, J1
Martelli, S1
Piacentini, P1
Bonetti, A1
Fasano, R1
Kent, P1
Valentino, L1

Reviews

1 review available for dalteparin and Superior Vena Cava Obstruction

ArticleYear
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
    Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:12

    Topics: Anti-Bacterial Agents; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C

2005

Other Studies

2 other studies available for dalteparin and Superior Vena Cava Obstruction

ArticleYear
Bullous hemorrhagic dermatosis distant from the site of heparin injection.
    Dermatology online journal, 2014, Oct-15, Volume: 20, Issue:10

    Topics: Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injections; Skin Diseases, Vesiculobull

2014
Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".
    Tumori, 2015, Mar-20, Volume: 101, Issue:1

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro

2015